Over 14 Years Treating Chronic Pain
Over the last two decades, we have seen opioids as a primary means to treat a variety of severe chronic pain syndromes, while some patients have had benefit, we know that these medicines carry the potential for abuse, addiction and diversion into our communities. Many of our other adjuvant (non-opioid) medications for pain (NSAIDS, neuropathic medications, skeletal muscle relaxers) also contain a significant side effect profile (renal failure, elevated stroke and heart attack risk, internal bleeding, slurred speech, visual disturbances) that many patients and physicians find unpalatable.
The ability to treat various pain syndromes with medicines that don’t impair and elevate serious medical and behavioral risk factors has been our driving force to develop a product line of cannabidiol that is catered to specific pain syndromes and well-being in a manner that is completely separate from how we are currently treating pain. We have also implemented strategies to combine and optimize the synergistic benefits from cannabidiol (CBD) with other well studied and commonly efficacious supplements specific to various conditions for those that are looking for optimal pain relief.